[Breaking] KakaoPay Surges 7.68% in After-Hours NXT Trading... Buying Expands as It Recovers 40,000-Won Level in Regular Session
KakaoPay (377300) is attracting investor attention by expanding its gains in after-hours NXT (general/standalone type) trading, following its recovery of the 40
![[Breaking] KakaoPay Surges 7.68% in After-Hours NXT Trading... Buying Expands as It Recovers 40,000-Won Level in Regular Session](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581911%2Fa630da1c47d6049c%2Foriginal.webp&w=1920&q=75)
KakaoPay (377300) is attracting investor attention by expanding its gains in after-hours NXT (general/standalone type) trading, following its recovery of the 40,000-won level during the regular trading session on the same day.
As of 4:42 p.m. on the 21st, KakaoPay is trading at 42,750 won in the after-hours NXT session. This represents a 3,050-won (7.68%) increase from the previous day's closing price. During the session, it briefly surpassed the 44,000-won level, fueling expectations of a recovery in investor sentiment.
Earlier, KakaoPay closed at 40,800 won in the KRX regular market on the same day, up 1,100 won (2.77%) from the previous trading day. Following the recovery of the 40,000-won level in the regular session, buying pressure has continued to flow into after-hours trading, further widening the upward trend.
On the same day, the domestic stock market showed overall strength. Both the KOSPI and KOSDAQ closed higher, extending the trend of improving investor sentiment.
However, whether the strength in after-hours trading will carry over to the next trading day's regular session remains uncertain, with overall market investor sentiment and supply-demand dynamics cited as key variables.
[This article is not intended to solicit investment. The final judgment and responsibility for all investments lie with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] April Bio Signs License-in Agreement with Qurigen for Dual-Target siRNA Metabolic Disease Therapeutics](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F579783%2F4e4da2bfb8f012b9%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking] Samhyun (437730) Surges 19% in After-Hours NXT Trading, Recovering '30,000 Won Level'... Robot Stocks Rally](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581419%2F479dac739b049517%2Fvariants%2Fhero.webp&w=1920&q=75)
